{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:15:37Z","timestamp":1791346537608,"version":"4.3.1"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Singapore Ministry of Health\u2019s NMRC Open Fund-Individual Research Grant","award":["MOH-OFIRG21nov-0007"],"award-info":[{"award-number":["MOH-OFIRG21nov-0007"]}]},{"name":"National University of Singapore startup grant","award":["NUHSRO\/2023\/005\/STARTUP\/3"],"award-info":[{"award-number":["NUHSRO\/2023\/005\/STARTUP\/3"]}]},{"name":"the NMRC Centre Grant awarded to National University Cancer Institute of Singapore"},{"name":"the Gilead Research Scholars Award provided by Gilead Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"DOI":"10.1186\/s12929-026-01277-4","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:14:51Z","timestamp":1785143691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The current landscape of mRNA therapy and the strategies for mRNA purification and dsRNA removal"],"prefix":"10.1186","volume":"33","author":[{"given":"Jin-He","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Bin","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Wen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Wen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"1","key":"1277_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01807-w","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M. The use of RNA-based treatments in the field of cancer immunotherapy. Mol Cancer. 2023;22(1):106.","journal-title":"Mol Cancer"},{"issue":"1","key":"1277_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2307187","volume":"20","author":"R Yao","year":"2024","unstructured":"Yao R, Xie C, Xia X. Recent progress in mRNA cancer vaccines. Hum Vaccin Immunother. 2024;20(1):2307187.","journal-title":"Hum Vaccin Immunother"},{"issue":"7978","key":"1277_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","volume":"621","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang L, Lin A, Xu C, Li Z, Liu K, et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature. 2023;621(7978):396\u2013403.","journal-title":"Nature"},{"issue":"6","key":"1277_CR4","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3390\/biomedicines11061735","volume":"11","author":"O Daly","year":"2023","unstructured":"Daly O, Mahiny AJ, Majeski S, McClintock K, Reichert J, Boros G, et al. ASL mRNA-LNP therapeutic for the treatment of argininosuccinic aciduria enables survival benefit in a mouse model. Biomedicines. 2023;11(6):1735.","journal-title":"Biomedicines"},{"issue":"19","key":"1277_CR5","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1039\/D4BM00909F","volume":"12","author":"P Arjunan","year":"2024","unstructured":"Arjunan P, Mahalingam G, Sankar P, Kathirvelu D, Suresh S, Rani S, et al. Base-modified factor VIII mRNA delivery with galactosylated lipid nanoparticles as a protein replacement therapy for haemophilia A. Biomater Sci. 2024;12(19):5052\u201362.","journal-title":"Biomater Sci"},{"issue":"9","key":"1277_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092182","volume":"15","author":"J Zhang","year":"2023","unstructured":"Zhang J, Liu Y, Li C, Xiao Q, Zhang D, Chen Y, et al. Recent advances and innovations in the preparation and purification of in vitro-transcribed-mRNA-based molecules. Pharmaceutics. 2023;15(9):2182.","journal-title":"Pharmaceutics"},{"issue":"19","key":"1277_CR7","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"SJ Thomas","year":"2021","unstructured":"Thomas SJ, Moreira ED Jr., Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021;385(19):1761\u201373.","journal-title":"N Engl J Med"},{"issue":"5","key":"1277_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"issue":"4","key":"1277_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297833","volume":"19","author":"ZB Reneer","year":"2024","unstructured":"Reneer ZB, Bergeron HC, Reynolds S, Thornhill-Wadolowski E, Feng L, Bugno M, et al. mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge. PLoS ONE. 2024;19(4):e0297833.","journal-title":"PLoS ONE"},{"key":"1277_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110125","volume":"596","author":"Y Tian","year":"2024","unstructured":"Tian Y, Deng Z, Chuai Z, Li C, Chang L, Sun F, et al. A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge. Virology. 2024;596:110125.","journal-title":"Virology"},{"issue":"7","key":"1277_CR11","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/acs.biomac.4c00365","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhuang X, Hu Y, Chen J, Hao K, Tang Z, et al. Constructing a ready-to-use mRNA vaccine delivery system for the prevention of influenza A virus, utilizing FDA-approved raw materials. Biomacromol. 2024;25(7):4281\u201391.","journal-title":"Biomacromol"},{"issue":"24","key":"1277_CR12","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","volume":"389","author":"E Wilson","year":"2023","unstructured":"Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, et al. Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults. N Engl J Med. 2023;389(24):2233\u201344.","journal-title":"N Engl J Med"},{"key":"1277_CR13","unstructured":"ModernaTX I. 2023 2026-07-10. A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes. U.S. National Library of Medicine\uff08NLM\uff09https:\/\/clinicaltrials.gov\/study\/NCT06033261. Accessed 10 Jul 2026"},{"issue":"6","key":"1277_CR14","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani A, Dulberger CL, De Silva NS, Marquette M, Lu YJ, Palowitch GM, et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell. 2024;187(6):1363-1373.e1312.","journal-title":"Cell"},{"issue":"8","key":"1277_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.109270","volume":"35","author":"Y Tian","year":"2024","unstructured":"Tian Y, Li M, Yang Y, Li C, Peng Y, Yang H, et al. An MPXV mRNA-LNP vaccine candidate elicits protective immune responses against monkeypox virus. Chin Chem Lett. 2024;35(8):109270.","journal-title":"Chin Chem Lett"},{"key":"1277_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105974","volume":"230","author":"E Li","year":"2024","unstructured":"Li E, Gong Q, Zhang J, Guo X, Xie W, Chen D, et al. An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge. Antivir Res. 2024;230:105974.","journal-title":"Antivir Res"},{"issue":"10427","key":"1277_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","volume":"403","author":"JS Weber","year":"2024","unstructured":"Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, et al. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study. Lancet. 2024;403(10427):632\u201344.","journal-title":"Lancet"},{"key":"1277_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bej.2024.109412","volume":"210","author":"L Guo","year":"2024","unstructured":"Guo L, Liu Z, Song S, Yao W, Yang M, Chen G. Maximizing the mRNA productivity for in vitro transcription by optimization of fed-batch strategy. Biochem Eng J. 2024;210:109412.","journal-title":"Biochem Eng J"},{"issue":"30","key":"1277_CR19","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1039\/D4AY00560K","volume":"16","author":"SS Rosa","year":"2024","unstructured":"Rosa SS, Zhang S, Sari Y, Marques MPC. A (RP)UHPLC\/UV analytical method to quantify dsRNA during the mRNA vaccine manufacturing process. Anal Methods. 2024;16(30):5146\u201353.","journal-title":"Anal Methods"},{"key":"1277_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1248511","volume":"10","author":"J Mart\u00ednez","year":"2023","unstructured":"Mart\u00ednez J, Lampaya V, Larraga A, Magall\u00f3n H, Casabona D. Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction. Front Mol Biosci. 2023;10:1248511.","journal-title":"Front Mol Biosci"},{"key":"1277_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2023.464321","volume":"1707","author":"X Feng","year":"2023","unstructured":"Feng X, Su Z, Cheng Y, Ma G, Zhang S. Messenger RNA chromatographic purification: advances and challenges. J Chromatogr A. 2023;1707:464321.","journal-title":"J Chromatogr A"},{"issue":"17-18","key":"1277_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/elps.202400036","volume":"45","author":"NE Clark","year":"2024","unstructured":"Clark NE, Schraut MR, Winters RA, Kearns K, Scanlon TC. An immuno-northern technique to measure the size of dsRNA byproducts in in vitro transcribed RNA. Electrophoresis. 2024;45(17\u201318):1546\u201354.","journal-title":"Electrophoresis"},{"issue":"18","key":"1277_CR23","doi-asserted-by":"publisher","first-page":"9253","DOI":"10.1093\/nar\/gky796","volume":"46","author":"Y Gholamalipour","year":"2018","unstructured":"Gholamalipour Y, Karunanayake Mudiyanselage A, Martin CT. 3\u2019 end additions by T7 RNA polymerase are RNA self-templated, distributive and diverse in character-RNA-Seq analyses. Nucleic Acids Res. 2018;46(18):9253\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"44","key":"1277_CR24","doi-asserted-by":"publisher","first-page":"17789","DOI":"10.1021\/acs.analchem.4c04162","volume":"96","author":"J Camperi","year":"2024","unstructured":"Camperi J, Roper B, Freund E, Leylek R, Nissenbaum A, Galan C, et al. Exploring the impact of in vitro-transcribed mRNA impurities on cellular responses. Anal Chem. 2024;96(44):17789\u201399.","journal-title":"Anal Chem"},{"issue":"12","key":"1277_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/gen.39.12.15","volume":"39","author":"B Roy","year":"2019","unstructured":"Roy B, Wu MZ. Understanding and overcoming the immune response from synthetic mRNAs. Genet Eng Biotechnol News. 2019;39(12):56\u20138.","journal-title":"Genet Eng Biotechnol News"},{"key":"1277_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113900","volume":"176","author":"AK Minnaert","year":"2021","unstructured":"Minnaert AK, Vanluchene H, Verbeke R, Lentacker I, De Smedt SC, Raemdonck K, et al. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across. Adv Drug Deliv Rev. 2021;176:113900.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5801","key":"1277_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.1132998","volume":"314","author":"A Pichlmair","year":"2006","unstructured":"Pichlmair A, Schulz O, Tan CP, N\u00e4slund TI, Liljestr\u00f6m P, Weber F, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5\u2019-phosphates. Science. 2006;314(5801):997\u20131001.","journal-title":"Science"},{"issue":"9","key":"1277_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel J, Gack MU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol. 2020;20(9):537\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"1277_CR29","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1021\/acs.accounts.1c00521","volume":"54","author":"X Mu","year":"2021","unstructured":"Mu X, Hur S. Immunogenicity of in vitro-transcribed RNA. Acc Chem Res. 2021;54(21):4012\u201323.","journal-title":"Acc Chem Res"},{"issue":"4","key":"1277_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.molcel.2016.04.021","volume":"62","author":"E Uchikawa","year":"2016","unstructured":"Uchikawa E, Lethier M, Malet H, Brunel J, Gerlier D, Cusack S. Structural analysis of dsRNA binding to anti-viral pattern recognition receptors LGP2 and MDA5. Mol Cell. 2016;62(4):586\u2013602.","journal-title":"Mol Cell"},{"issue":"49","key":"1277_CR31","doi-asserted-by":"publisher","first-page":"E3340","DOI":"10.1073\/pnas.1208618109","volume":"109","author":"A Peisley","year":"2012","unstructured":"Peisley A, Jo MH, Lin C, Wu B, Orme-Johnson M, Walz T, et al. Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments. Proc Natl Acad Sci USA. 2012;109(49):E3340-3349.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1277_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00833-16","volume":"7","author":"AF Durbin","year":"2016","unstructured":"Durbin AF, Wang C, Marcotrigiano J, Gehrke L. RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling. MBio. 2016;7(5):e00833-00816.","journal-title":"MBio"},{"issue":"17","key":"1277_CR33","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.1093\/nar\/gkq347","volume":"38","author":"BR Anderson","year":"2010","unstructured":"Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 2010;38(17):5884\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1277_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01883-23","volume":"98","author":"H Witwit","year":"2024","unstructured":"Witwit H, Khafaji R, Salaniwal A, Kim AS, Cubitt B, Jackson N, et al. Activation of protein kinase receptor (PKR) plays a pro-viral role in mammarenavirus-infected cells. J Virol. 2024;98(3):e01883-23.","journal-title":"J Virol"},{"key":"1277_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041356","volume":"37","author":"S Hur","year":"2019","unstructured":"Hur S. Double-stranded RNA sensors and modulators in innate immunity. Annu Rev Immunol. 2019;37:349\u201375.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"1277_CR36","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1073\/pnas.1519657113","volume":"113","author":"Y Li","year":"2016","unstructured":"Li Y, Banerjee S, Wang Y, Goldstein SA, Dong B, Gaughan C, et al. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses. Proc Natl Acad Sci USA. 2016;113(8):2241\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1277_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41580-021-00430-1","volume":"23","author":"YG Chen","year":"2022","unstructured":"Chen YG, Hur S. Cellular origins of dsRNA, their recognition and consequences. Nat Rev Mol Cell Biol. 2022;23(4):286\u2013301.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1277_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1073\/pnas.0710779105","volume":"105","author":"JN Leonard","year":"2008","unstructured":"Leonard JN, Ghirlando R, Askins J, Bell JK, Margulies DH, Davies DR, et al. The TLR3 signaling complex forms by cooperative receptor dimerization. Proc Natl Acad Sci USA. 2008;105(1):258\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1277_CR39","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.20080091","volume":"205","author":"H Kato","year":"2008","unstructured":"Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 2008;205(7):1601\u201310.","journal-title":"J Exp Med"},{"issue":"2","key":"1277_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2018.08.021","volume":"72","author":"SC Devarkar","year":"2018","unstructured":"Devarkar SC, Schweibenz B, Wang C, Marcotrigiano J, Patel SS. RIG-I uses an ATPase-powered translocation-throttling mechanism for kinetic proofreading of RNAs and oligomerization. Mol Cell. 2018;72(2):355-368.e354.","journal-title":"Mol Cell"},{"issue":"8","key":"1277_CR41","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.celrep.2019.01.107","volume":"26","author":"X Ren","year":"2019","unstructured":"Ren X, Linehan MM, Iwasaki A, Pyle AM. RIG-I selectively discriminates against 5\u2019-monophosphate RNA. Cell Rep. 2019;26(8):2019-2027.e2014.","journal-title":"Cell Rep"},{"issue":"5","key":"1277_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.coi.2011.08.009","volume":"23","author":"CK Pfaller","year":"2011","unstructured":"Pfaller CK, Li Z, George CX, Samuel CE. Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Curr Opin Immunol. 2011;23(5):573\u201382.","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"1277_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2005.06.044","volume":"122","author":"AC Dar","year":"2005","unstructured":"Dar AC, Dever TE, Sicheri F. Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Cell. 2005;122(6):887\u2013900.","journal-title":"Cell"},{"issue":"6176","key":"1277_CR44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1249845","volume":"343","author":"Y Han","year":"2014","unstructured":"Han Y, Donovan J, Rath S, Whitney G, Chitrakar A, Korennykh A. Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response. Science. 2014;343(6176):1244\u20138.","journal-title":"Science"},{"issue":"1","key":"1277_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molcel.2023.11.033","volume":"84","author":"KA Cottrell","year":"2024","unstructured":"Cottrell KA, Andrews RJ, Bass BL. The competitive landscape of the dsRNA world. Mol Cell. 2024;84(1):107\u201319.","journal-title":"Mol Cell"},{"issue":"1","key":"1277_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-024-01840-1","volume":"22","author":"A Dhakal","year":"2024","unstructured":"Dhakal A, Salim C, Skelly M, Amichan Y, Lamm AT, Hundley HA. ADARs regulate cuticle collagen expression and promote survival to pathogen infection. BMC Biol. 2024;22(1):37.","journal-title":"BMC Biol"},{"issue":"11","key":"1277_CR47","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1111\/ijd.16692","volume":"62","author":"R Linares-Navarro","year":"2023","unstructured":"Linares-Navarro R, Delgado-Vicente S, Jim\u00e9nez-Gonz\u00e1lez A, Onecha-Vallejo V, Criado-Otero M. Aicardi-Gouti\u00e8res syndrome and dyschromatosis symmetrica hereditaria due to compound heterozygous mutation of ADAR1, presentation of two cases. Int J Dermatol. 2023;62(11):e580\u20131.","journal-title":"Int J Dermatol"},{"issue":"21","key":"1277_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr695","volume":"39","author":"K Karik\u00f3","year":"2011","unstructured":"Karik\u00f3 K, Muramatsu H, Ludwig J, Weissman D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 2011;39(21):e142.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1277_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5423","volume":"9","author":"E Ochoa","year":"2023","unstructured":"Ochoa E, Ramirez P, Gonzalez E, De Mange J, Ray WJ, Bieniek KF, et al. Pathogenic tau\u2013induced transposable element\u2013derived dsRNA drives neuroinflammation. Sci Adv. 2023;9(1):eabq5423.","journal-title":"Sci Adv"},{"key":"1277_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-62703-260-5_3","volume":"969","author":"D Weissman","year":"2013","unstructured":"Weissman D, Pardi N, Muramatsu H, Karik\u00f3 K. HPLC purification of in vitro transcribed long RNA. Methods Mol Biol. 2013;969:43\u201354.","journal-title":"Methods Mol Biol"},{"issue":"8","key":"1277_CR51","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/vaccines12080899","volume":"12","author":"DA Holland","year":"2024","unstructured":"Holland DA, Acevedo-Skrip J, Barton J, Thompson R, Bowman A, Dewar EA, et al. Development and application of automated sandwich ELISA for quantitating residual dsRNA in mRNA vaccines. Vaccines (Basel). 2024;12(8):899.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"1277_CR52","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/15476286.2022.2139113","volume":"19","author":"H Xia","year":"2022","unstructured":"Xia H, Yu B, Jiang Y, Cheng R, Lu X, Wu H, et al. Psychrophilic phage VSW-3 RNA polymerase reduces both terminal and full-length dsRNA byproducts in in vitro transcription. RNA Biol. 2022;19(1):1130\u201342.","journal-title":"RNA Biol"},{"key":"1277_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1291045","volume":"10","author":"T Ziegenhals","year":"2023","unstructured":"Ziegenhals T, Frieling R, Wolf P, G\u00f6bel K, Koch S, Lohmann M, et al. Formation of dsRNA by-products during in vitro transcription can be reduced by using low steady-state levels of UTP. Front Mol Biosci. 2023;10:1291045.","journal-title":"Front Mol Biosci"},{"key":"1277_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.omtn.2022.08.001","volume":"29","author":"X Piao","year":"2022","unstructured":"Piao X, Yadav V, Wang E, Chang W, Tau L, Lindenmuth BE, et al. Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA. Mol Ther Nucleic Acids. 2022;29:618\u201324.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"1277_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.102033","volume":"4","author":"IJS de Faria","year":"2023","unstructured":"de Faria IJS, Imler JL, Marques JT. Protocol for the analysis of double-stranded RNAs in virus-infected insect cells using anti-dsRNA antibodies. STAR Protoc. 2023;4(1):102033.","journal-title":"STAR Protoc"},{"key":"1277_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.omtn.2023.04.005","volume":"32","author":"D Luo","year":"2023","unstructured":"Luo D, Wu Z, Wang D, Zhang J, Shao F, Wang S, et al. Lateral flow immunoassay for rapid and sensitive detection of dsRNA contaminants in in vitro-transcribed mRNA products. Mol Ther Nucleic Acids. 2023;32:445\u201353.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"16","key":"1277_CR57","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1039\/D3AN00281K","volume":"148","author":"A Coll De Pe\u00f1a","year":"2023","unstructured":"Coll De Pe\u00f1a A, Li N, Vaduva M, Bwanali L, Tripathi A. A microfluidic electrophoretic dual dynamic staining method for the identification and relative quantitation of dsRNA contaminants in mRNA vaccines. Analyst. 2023;148(16):3758\u201367.","journal-title":"Analyst"},{"key":"1277_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-981-15-1547-7_13","volume-title":"Essentials of pharmaceutical analysis","author":"MSH Akash","year":"2020","unstructured":"Akash MSH, Rehman K. Column chromatography. In: Essentials of pharmaceutical analysis. Singapore: Springer Nature Singapore; 2020. p. 167\u201374."},{"issue":"16","key":"1277_CR59","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","volume":"39","author":"SS Rosa","year":"2021","unstructured":"Rosa SS, Prazeres DMF, Azevedo AM, Marques MPC. mRNA vaccines manufacturing: challenges and bottlenecks. Vaccine. 2021;39(16):2190\u2013200.","journal-title":"Vaccine"},{"issue":"16","key":"1277_CR60","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1039\/C9AN00954J","volume":"144","author":"AO Nwokeoji","year":"2019","unstructured":"Nwokeoji AO, Kumar S, Kilby PM, Portwood DE, Hobbs JK, Dickman MJ. Analysis of long dsRNA produced in vitro and in vivo using atomic force microscopy in conjunction with ion-pair reverse-phase HPLC. Analyst. 2019;144(16):4985\u201394.","journal-title":"Analyst"},{"key":"1277_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chroma.2016.12.062","volume":"1484","author":"AO Nwokeoji","year":"2017","unstructured":"Nwokeoji AO, Kung A-W, Kilby PM, Portwood DE, Dickman MJ. Purification and characterisation of dsRNA using ion pair reverse phase chromatography and mass spectrometry. J Chromatogr A. 2017;1484:14\u201325.","journal-title":"J Chromatogr A"},{"issue":"3","key":"1277_CR62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s44211-022-00253-w","volume":"39","author":"T Kuwayama","year":"2023","unstructured":"Kuwayama T, Ozaki M, Shimotsuma M, Hirose T. Separation of long-stranded RNAs by RP-HPLC using an octadecyl-based column with super-wide pores. Anal Sci. 2023;39(3):417\u201325.","journal-title":"Anal Sci"},{"key":"1277_CR63","first-page":"43","volume-title":"Methods in molecular biology","author":"D Weissman","year":"2013","unstructured":"Weissman D, Pardi N, Muramatsu H, Karik\u00f3 K. HPLC purification of in vitro transcribed long RNA. In: Rabinovich PM, editor. Methods in molecular biology. Totowa: Humana Press; 2013. p. 43\u201354."},{"issue":"1","key":"1277_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38244-8","volume":"14","author":"M Inagaki","year":"2023","unstructured":"Inagaki M, Abe N, Li Z, Nakashima Y, Acharyya S, Ogawa K, et al. Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures. Nat Commun. 2023;14(1):2657.","journal-title":"Nat Commun"},{"issue":"12","key":"1277_CR65","doi-asserted-by":"publisher","first-page":"8149","DOI":"10.1021\/jacs.3c12629","volume":"146","author":"M Warminski","year":"2024","unstructured":"Warminski M, Trepkowska E, Smietanski M, Sikorski PJ, Baranowski MR, Bednarczyk M, et al. Trinucleotide mRNA cap analogue N6-benzylated at the site of posttranscriptional (m6)A(m) mark facilitates mRNA purification and confers superior translational properties in vitro and in vivo. J Am Chem Soc. 2024;146(12):8149\u201363.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"1277_CR66","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1261\/rna.075697.120","volume":"26","author":"H Karlsson","year":"2020","unstructured":"Karlsson H, Baronti L, Petzold K. A robust and versatile method for production and purification of large-scale RNA samples for structural biology. RNA. 2020;26(8):1023\u201337.","journal-title":"RNA"},{"issue":"2","key":"1277_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102491","volume":"36","author":"A Kru\u0161i\u010d","year":"2025","unstructured":"Kru\u0161i\u010d A, Mencin N, Leban M, Nett E, Perkovi\u0107 M, Sahin U, et al. Reverse-phase chromatography removes double-stranded RNA, fragments, and residual template to decrease immunogenicity and increase cell potency of mRNA and saRNA. Mol Ther Nucleic Acids. 2025;36(2):102491.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"13","key":"1277_CR68","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1039\/D4AY00114A","volume":"16","author":"M Ozaki","year":"2024","unstructured":"Ozaki M, Kuwayama T, Shimotsuma M, Hirose T. Separation and purification of short-, medium-, and long-stranded RNAs by RP-HPLC using different mobile phases and C(18) columns with various pore sizes. Anal Methods. 2024;16(13):1948\u201356.","journal-title":"Anal Methods"},{"issue":"2","key":"1277_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12020102","volume":"12","author":"A Wadhwa","year":"2020","unstructured":"Wadhwa A, Aljabbari A, Lokras A, Foged C, Thakur A. Opportunities and challenges in the delivery of mRNA-based vaccines. Pharmaceutics. 2020;12(2):102.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1277_CR70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.smim.2013.05.001","volume":"25","author":"AJ Geall","year":"2013","unstructured":"Geall AJ, Mandl CW, Ulmer JB. RNA: the new revolution in nucleic acid vaccines. Semin Immunol. 2013;25(2):152\u20139.","journal-title":"Semin Immunol"},{"key":"1277_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.465576","volume":"1740","author":"YY Siew","year":"2025","unstructured":"Siew YY, Zhang W. Removing immunogenic double-stranded RNA impurities post in vitro transcription synthesis for mRNA therapeutics production: a review of chromatography strategies. J Chromatogr A. 2025;1740:465576.","journal-title":"J Chromatogr A"},{"key":"1277_CR72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","volume":"15","author":"M Baiersd\u00f6rfer","year":"2019","unstructured":"Baiersd\u00f6rfer M, Boros G, Muramatsu H, Mahiny A, Vlatkovic I, Sahin U, et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol Ther Nucleic Acids. 2019;15:26\u201335.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"1277_CR73","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ymthe.2021.01.023","volume":"29","author":"Z Zhong","year":"2021","unstructured":"Zhong Z, McCafferty S, Opsomer L, Wang H, Huysmans H, De Temmerman J, et al. Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs. Mol Ther. 2021;29(4):1370\u201381.","journal-title":"Mol Ther"},{"key":"1277_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-0716-3702-9_4","volume":"2771","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang Z, Wu X. Rapid purification of dsRNA using micro-spin cellulose column. Methods Mol Biol. 2024;2771:19\u201325.","journal-title":"Methods Mol Biol"},{"issue":"22","key":"1277_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303321","volume":"36","author":"X Yuan","year":"2024","unstructured":"Yuan X, Wu Z, Guo J, Luo D, Li T, Cao Q, et al. Natural wood-derived macroporous cellulose for highly efficient and ultrafast elimination of double-stranded RNA from in vitro-transcribed mRNA. Adv Mater. 2024;36(22):e2303321.","journal-title":"Adv Mater"},{"issue":"2","key":"1277_CR76","first-page":"386","volume":"14","author":"S Zuppolini","year":"2022","unstructured":"Zuppolini S, Salama A, Cruz-Maya I, Guarino V, Borriello A. Cellulose amphiphilic materials: chemistry. Process Appl Pharm. 2022;14(2):386.","journal-title":"Process Appl Pharm"},{"issue":"1","key":"1277_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10570-021-04325-4","volume":"29","author":"M Wohlert","year":"2022","unstructured":"Wohlert M, Benselfelt T, W\u00e5gberg L, Fur\u00f3 I, Berglund LA, Wohlert J. Cellulose and the role of hydrogen bonds: not in charge of everything. Cellulose. 2022;29(1):1\u201323.","journal-title":"Cellulose"},{"issue":"6","key":"1277_CR78","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10517-024-06102-2","volume":"176","author":"SV Sharabrin","year":"2024","unstructured":"Sharabrin SV, Bondar AA, Starostina EV, Kisakov DN, Kisakova LA, Zadorozhny AM, et al. Removal of Double-Stranded RNA Contaminants During Template-Directed Synthesis of mRNA. Bull Exp Biol Med. 2024;176(6):751\u20135.","journal-title":"Bull Exp Biol Med"},{"key":"1277_CR79","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.omtn.2021.10.007","volume":"26","author":"S Linares-Fern\u00e1ndez","year":"2021","unstructured":"Linares-Fern\u00e1ndez S, Moreno J, Lambert E, Mercier-Gouy P, Vachez L, Verrier B, et al. Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA. Mol Ther Nucleic Acids. 2021;26:945\u201356.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"18","key":"1277_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307541","volume":"11","author":"S Son","year":"2024","unstructured":"Son S, Park M, Kim J, Lee K. ACE mRNA (additional chimeric element incorporated IVT mRNA) for enhancing protein expression by modulating immunogenicity. Adv Sci (Weinh). 2024;11(18):e2307541.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"1277_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12080899","volume":"12","author":"DA Holland","year":"2024","unstructured":"Holland DA, Acevedo-Skrip J, Barton J, Thompson R, Bowman A, Dewar EA, et al. Development and application of automated sandwich ELISA for quantitating residual dsRNA in mRNA vaccines. Vaccines Basel. 2024;12(8):899.","journal-title":"Vaccines Basel"},{"issue":"16","key":"1277_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416629","volume":"12","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Li W, Ren X, Luo D, Yuan X, Yu L, et al. Mitigating cellular dysfunction through contaminant reduction in synthetic circRNA for high-efficiency mRNA-based cell reprogramming. Adv Sci (Weinh). 2025;12(16):e2416629.","journal-title":"Adv Sci (Weinh)"},{"key":"1277_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114204","volume":"196","author":"H Vanluchene","year":"2024","unstructured":"Vanluchene H, Gillon O, Peynshaert K, De Smedt SC, Sanders N, Raemdonck K, et al. Less is more: self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells. Eur J Pharm Biopharm. 2024;196:114204.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1277_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00932-x","volume":"9","author":"X Cui","year":"2024","unstructured":"Cui X, Vervaeke P, Gao Y, Opsomer L, Sun Q, Snoeck J, et al. Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza. NPJ Vaccines. 2024;9(1):138.","journal-title":"NPJ Vaccines"},{"issue":"2","key":"1277_CR85","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1089\/hum.2018.145","volume":"30","author":"JB Foster","year":"2019","unstructured":"Foster JB, Choudhari N, Perazzelli J, Storm J, Hofmann TJ, Jain P, et al. Purification of mRNA encoding chimeric antigen receptor is critical for generation of a robust T-cell response. Hum Gene Ther. 2019;30(2):168\u201378.","journal-title":"Hum Gene Ther"},{"issue":"6","key":"1277_CR86","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1073\/pnas.69.6.1408","volume":"69","author":"H Aviv","year":"1972","unstructured":"Aviv H, Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA. 1972;69(6):1408\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1277_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.464670","volume":"1717","author":"EA Dewar","year":"2024","unstructured":"Dewar EA, Guterstam P, Holland D, Lindman S, Lundb\u00e4ck P, Brito dos Santos S, et al. Improved mRNA affinity chromatography binding capacity and throughput using an oligo-dT immobilized electrospun polymer nanofiber adsorbent. J Chromatogr A. 2024;1717:464670.","journal-title":"J Chromatogr A"},{"key":"1277_CR88","unstructured":"Perisic S, Senigaglia U, Dolenc D, Cannon PS. Method for purifying single-stranded RNA. Canada. 2023."},{"key":"1277_CR89","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.18609\/cgti.2020.114","volume":"6","author":"P Gagnon","year":"2020","unstructured":"Gagnon P, Gori\u010dar B, Per\u0161i\u010d \u0160, \u010cernigoj U, \u0160trancar A. Two new capture options for improved purification of large mRNA. Cell Gene Ther Insights. 2020;6:1035\u201346.","journal-title":"Cell Gene Ther Insights"},{"issue":"5","key":"1277_CR90","doi-asserted-by":"publisher","first-page":"489","DOI":"10.18609\/cgti.2021.073","volume":"7","author":"K Flook","year":"2021","unstructured":"Flook K. Supporting development of mRNA-based therapies by addressing large-scale purification challenges. Cell Gene Ther Insights. 2021;7(5):489\u2013502.","journal-title":"Cell Gene Ther Insights"},{"issue":"9","key":"1277_CR91","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.18609\/cgti.2021.161","volume":"7","author":"M Koren\u010d","year":"2021","unstructured":"Koren\u010d M, Mencin N, Puc J, Skok J, Nemec K\u0160, Celjar AM, et al. Chromatographic purification with CIMmultus\u2122 Oligo dT increases mRNA stability. Cell Gene Ther Insights. 2021;7(9):1207\u201316.","journal-title":"Cell Gene Ther Insights"},{"key":"1277_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bej.2023.109213","volume":"203","author":"Y-Z Tan","year":"2024","unstructured":"Tan Y-Z, Qiao L-Z, Wang S-S, Zhang J, Qian J, Zhu M, et al. Enhanced adsorption performance of varying-length mRNA on Oligo dT affinity resins through optimal pore size and grafting. Biochem Eng J. 2024;203:109213.","journal-title":"Biochem Eng J"},{"key":"1277_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2022.122320","volume":"304","author":"N Mencin","year":"2023","unstructured":"Mencin N, \u0160tepec D, Margon A, Vidi\u010d J, Dolenc D, Sim\u010di\u010d T, et al. Development and scale-up of oligo-dT monolithic chromatographic column for mRNA capture through understanding of base-pairing interactions. Sep Purif Technol. 2023;304:122320.","journal-title":"Sep Purif Technol"},{"issue":"11","key":"1277_CR94","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1002\/bit.28806","volume":"121","author":"J Boman","year":"2024","unstructured":"Boman J, Maru\u0161i\u010d T, Seravalli TV, Skok J, Pettersson F, Nemec K, et al. Quality by design approach to improve quality and decrease cost of in vitro transcription of mRNA using design of experiments. Biotechnol Bioeng. 2024;121(11):3415\u201327.","journal-title":"Biotechnol Bioeng"},{"key":"1277_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.115174","volume":"224","author":"S Fekete","year":"2023","unstructured":"Fekete S, Doneanu C, Addepalli B, Gaye M, Nguyen J, Alden B, et al. Challenges and emerging trends in liquid chromatography-based analyses of mRNA pharmaceuticals. J Pharm Biomed Anal. 2023;224:115174.","journal-title":"J Pharm Biomed Anal"},{"key":"1277_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.464871","volume":"1722","author":"M Xu","year":"2024","unstructured":"Xu M, Wu Z. A mixed-mode reversed-phase\/strong-anion-exchange stationary phase: analyte-retention stability and application in the analysis of nonsteroidal anti-inflammatory drugs. J Chromatogr A. 2024;1722:464871.","journal-title":"J Chromatogr A"},{"issue":"4","key":"1277_CR97","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/molecules27041389","volume":"27","author":"V Elhami","year":"2022","unstructured":"Elhami V, Antunes EC, Temmink H, Schuur B. Recovery techniques enabling circular chemistry from wastewater. Molecules. 2022;27(4):1389.","journal-title":"Molecules"},{"issue":"24","key":"1277_CR98","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/elps.202300106","volume":"44","author":"P Megu\u0161ar","year":"2023","unstructured":"Megu\u0161ar P, Miklav\u010di\u010d R, Koren\u010d M, Li\u010den J, Vodopivec T, \u010cernigoj U, et al. Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance. Electrophoresis. 2023;44(24):1978\u201388.","journal-title":"Electrophoresis"},{"issue":"18","key":"1277_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814267","volume":"24","author":"R Miklav\u010di\u010d","year":"2023","unstructured":"Miklav\u010di\u010d R, Megu\u0161ar P, Kodermac \u0160M, Bakalar B, Dolenc D, Sekirnik R, et al. High recovery chromatographic purification of mRNA at room temperature and neutral pH. Int J Mol Sci. 2023;24(18):14267.","journal-title":"Int J Mol Sci"},{"key":"1277_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1250833","volume":"11","author":"EN Welbourne","year":"2024","unstructured":"Welbourne EN, Loveday KA, Nair A, Nourafkan E, Qu J, Cook K, et al. Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development. Front Mol Biosci. 2024;11:1250833.","journal-title":"Front Mol Biosci"},{"key":"1277_CR101","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chroma.2012.12.050","volume":"1278","author":"A Romanovskaya","year":"2013","unstructured":"Romanovskaya A, Sarin LP, Bamford DH, Poranen MM. High-throughput purification of double-stranded RNA molecules using convective interaction media monolithic anion exchange columns. J Chromatogr A. 2013;1278:54\u201360.","journal-title":"J Chromatogr A"},{"key":"1277_CR102","unstructured":"Issa W.J., Barberio J.L., Aunins J.G. and Afeyan N.B.; Moderna therapeutics inc, assignee. Ion exchange purification of mRNA. WIPO (PCT) patent WO2014144767A1. 15 Mar 2013."},{"key":"1277_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.464862","volume":"1722","author":"V D\u2019Atri","year":"2024","unstructured":"D\u2019Atri V, Imio\u0142ek M, Quinn C, Finny A, Lauber M, Fekete S, et al. Size exclusion chromatography of biopharmaceutical products: from current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles. J Chromatogr A. 2024;1722:464862.","journal-title":"J Chromatogr A"},{"issue":"2","key":"1277_CR104","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1261\/rna.342607","volume":"13","author":"I Kim","year":"2007","unstructured":"Kim I, McKenna SA, Viani Puglisi E, Puglisi JD. Rapid purification of RNAs using fast performance liquid chromatography (FPLC). RNA. 2007;13(2):289\u201394.","journal-title":"RNA"},{"issue":"11","key":"1277_CR105","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/v13112272","volume":"13","author":"H Kaddour","year":"2021","unstructured":"Kaddour H, Tranquille M, Okeoma CM. The past, the present, and the future of the size exclusion chromatography in extracellular vesicles separation. Viruses. 2021;13(11):2272.","journal-title":"Viruses"},{"issue":"2","key":"1277_CR106","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jbbm.2003.10.001","volume":"58","author":"LK Kostanski","year":"2004","unstructured":"Kostanski LK, Keller DM, Hamielec AE. Size-exclusion chromatography\u2014a review of calibration methodologies. J Biochem Biophys Methods. 2004;58(2):159\u201386.","journal-title":"J Biochem Biophys Methods"},{"issue":"5","key":"1277_CR107","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1159\/000492512","volume":"48","author":"F Kanwal","year":"1915","unstructured":"Kanwal F, Chen T, Zhang Y, Zhang Y, Simair A, Rujie C, et al. Large-scale in vitro transcription, RNA purification and chemical probing analysis. Cell Physiol Biochem. 1915;48(5):1915\u201327.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"1277_CR108","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1261\/rna.5264804","volume":"10","author":"PJ Lukavsky","year":"2004","unstructured":"Lukavsky PJ, Puglisi JD. Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides. RNA. 2004;10(5):889\u201393.","journal-title":"RNA"},{"issue":"11","key":"1277_CR109","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.3390\/ijms25116254","volume":"25","author":"V D'Atri","year":"2024","unstructured":"D\u2019Atri V, Lardeux H, Goyon A, Imio\u0142ek M, Fekete S, Lauber M, et al. Optimizing Messenger RNA analysis using ultra-wide pore size exclusion chromatography columns. Int J Mol Sci. 2024;25(11):6254.","journal-title":"Int J Mol Sci"},{"key":"1277_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.464756","volume":"1719","author":"J De Vos","year":"2024","unstructured":"De Vos J, Morreel K, Alvarez P, Vanluchene H, Vankeirsbilck R, Sandra P, et al. Evaluation of size-exclusion chromatography, multi-angle light scattering detection and mass photometry for the characterization of mRNA. J Chromatogr A. 2024;1719:464756.","journal-title":"J Chromatogr A"},{"key":"1277_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2025.465972","volume":"1752","author":"M Buff","year":"2025","unstructured":"Buff M, Goyon A, Elger C, Ruppert R, Haindl M, Zhang K, et al. Systematic comparison of wide pore size exclusion chromatography columns for the characterization of gene therapy products. J Chromatogr A. 2025;1752:465972.","journal-title":"J Chromatogr A"},{"issue":"4","key":"1277_CR112","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41596-019-0126-x","volume":"14","author":"H Zhang","year":"2019","unstructured":"Zhang H, Lyden D. Asymmetric-flow field-flow fractionation technology for exomere and small extracellular vesicle separation and characterization. Nat Protoc. 2019;14(4):1027\u201353.","journal-title":"Nat Protoc"},{"key":"1277_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2019.07.001","volume":"1605","author":"M Marioli","year":"2019","unstructured":"Marioli M, Kavurt \u00dcB, Stamatialis D, Kok WT. Application of microstructured membranes for increasing retention, selectivity and resolution in asymmetrical flow field-flow fractionation. J Chromatogr A. 2019;1605:360347.","journal-title":"J Chromatogr A"},{"key":"1277_CR114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.aca.2013.11.021","volume":"809","author":"J Gigault","year":"2014","unstructured":"Gigault J, Pettibone JM, Schmitt C, Hackley VA. Rational strategy for characterization of nanoscale particles by asymmetric-flow field flow fractionation: a tutorial. Anal Chim Acta. 2014;809:9\u201324.","journal-title":"Anal Chim Acta"},{"key":"1277_CR115","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jchromb.2018.07.008","volume":"1095","author":"M Lampi","year":"2018","unstructured":"Lampi M, Oksanen HM, Meier F, Moldenhauer E, Poranen MM, Bamford DH, et al. Asymmetrical flow field-flow fractionation in purification of an enveloped bacteriophage \u03d56. J Chromatogr B. 2018;1095:251\u20137.","journal-title":"J Chromatogr B"},{"key":"1277_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2022.463525","volume":"1683","author":"E Katri","year":"2022","unstructured":"Katri E, Mirka L, Christine C, Jafargholi I, Karl-Heinz K, Poranen MM. Analysis and purification of ssRNA and dsRNA molecules using asymmetrical flow field flow fractionation. J Chromatogr A. 2022;1683:463525.","journal-title":"J Chromatogr A"},{"issue":"11","key":"1277_CR117","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1021\/ac501664t","volume":"86","author":"M Wagner","year":"2014","unstructured":"Wagner M, Holzschuh S, Traeger A, Fahr A, Schubert US. Asymmetric flow field-flow fractionation in the field of nanomedicine. Anal Chem. 2014;86(11):5201\u201310.","journal-title":"Anal Chem"},{"key":"1277_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2020.461767","volume":"1635","author":"F Caputo","year":"2021","unstructured":"Caputo F, Mehn D, Clogston JD, R\u00f6sslein M, Prina-Mello A, Borgos SE, et al. Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory. J Chromatogr A. 2021;1635:461767.","journal-title":"J Chromatogr A"},{"issue":"4","key":"1277_CR119","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1021\/acs.oprd.2c00291","volume":"27","author":"P Agrawal","year":"2023","unstructured":"Agrawal P, Wilkstein K, Guinn E, Mason M, Serrano Martinez CI, Saylae J. A review of tangential flow filtration: process development and applications in the pharmaceutical industry. Org Process Res Dev. 2023;27(4):571\u201391.","journal-title":"Org Process Res Dev"},{"issue":"7830","key":"1277_CR120","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586(7830):567\u201371.","journal-title":"Nature"},{"issue":"6","key":"1277_CR121","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.tibtech.2023.11.016","volume":"42","author":"A Javidanbardan","year":"2024","unstructured":"Javidanbardan A, Messerian KO, Zydney AL. Membrane technology for the purification of RNA and DNA therapeutics. Trends Biotechnol. 2024;42(6):714\u201327.","journal-title":"Trends Biotechnol"},{"key":"1277_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2025.132179","volume":"363","author":"A Behboudi","year":"2025","unstructured":"Behboudi A, Javidanbardan A, Wang Z, Zhou L, Zydney AL. Vibration-assisted ultrafiltration dramatically improves mRNA purification. Sep Purif Technol. 2025;363:132179.","journal-title":"Sep Purif Technol"},{"issue":"1","key":"1277_CR123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/(SICI)1097-0290(19971005)56:1<71::AID-BIT8>3.0.CO;2-S","volume":"56","author":"R van Reis","year":"1997","unstructured":"van Reis R, Gadam S, Frautschy LN, Orlando S, Goodrich EM, Saksena S, et al. High performance tangential flow filtration. Biotechnol Bioeng. 1997;56(1):71\u201382.","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"1277_CR124","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/membranes12020187","volume":"12","author":"RW Field","year":"2022","unstructured":"Field RW, Wu JJ. Permeate flux in ultrafiltration processes-understandings and misunderstandings. Membranes (Basel). 2022;12(2):187.","journal-title":"Membranes (Basel)"},{"issue":"11","key":"1277_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202400473","volume":"19","author":"E Nourafkan","year":"2024","unstructured":"Nourafkan E, Kenyon C, Nair A, Loveday KA, Welbourne EN, Tao M, et al. An experimental and modeling approach to study tangential flow filtration performance for mRNA drug substance purification. Biotechnol J. 2024;19(11):e202400473.","journal-title":"Biotechnol J"},{"key":"1277_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2022.120949","volume":"291","author":"E Madsen","year":"2022","unstructured":"Madsen E, Kaiser J, Kr\u00fchne U, Pinelo M. Single pass tangential flow filtration: critical operational variables, fouling, and main current applications. Sep Purif Technol. 2022;291:120949.","journal-title":"Sep Purif Technol"},{"key":"1277_CR127","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/B978-0-12-420037-1.00019-1","volume":"530","author":"SE Walker","year":"2013","unstructured":"Walker SE, Lorsch J. RNA purification\u2013precipitation methods. Methods Enzymol. 2013;530:337\u201343.","journal-title":"Methods Enzymol"},{"key":"1277_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2024.126331","volume":"336","author":"X Feng","year":"2024","unstructured":"Feng X, Li Z, Su Z, Che S, Dai B, Cheng Y, et al. Rapid and high recovery isolation of mRNA from in vitro transcription system by ammonium sulphate precipitation at room temperature. Sep Purif Technol. 2024;336:126331.","journal-title":"Sep Purif Technol"},{"key":"1277_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1381508","volume":"15","author":"EP Mazunina","year":"2024","unstructured":"Mazunina EP, Gushchin VA, Kleymenov DA, Siniavin AE, Burtseva EI, Shmarov MM, et al. Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response. Front Immunol. 2024;15:1381508.","journal-title":"Front Immunol"},{"key":"1277_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512408","author":"E Cho","year":"2023","unstructured":"Cho E, Namgung J, Lee JS, Jang J, Jun BH, Kim DE. Mesoporous silica particle as an RNA adsorbent for facile purification of in vitro-transcribed RNA. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241512408.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1277_CR131","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/jcm.28.3.495-503.1990","volume":"28","author":"R Boom","year":"1990","unstructured":"Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28(3):495\u2013503.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1277_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78202-8","volume":"10","author":"WP Hu","year":"2020","unstructured":"Hu WP, Chen YC, Chen WY. Improve sample preparation process for miRNA isolation from the culture cells by using silica fiber membrane. Sci Rep. 2020;10(1):21132.","journal-title":"Sci Rep"},{"issue":"3","key":"1277_CR133","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1261\/rna.073858.119","volume":"26","author":"MZ Wu","year":"2020","unstructured":"Wu MZ, Asahara H, Tzertzinis G, Roy B. Synthesis of low immunogenicity RNA with high-temperature in vitro transcription. RNA. 2020;26(3):345\u201360.","journal-title":"RNA"},{"issue":"5","key":"1277_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2022.100056","volume":"1","author":"G Wang","year":"2022","unstructured":"Wang G, Cheng R, Chen Q, Xu Y, Yu B, Zhu B, et al. mRNA produced by VSW-3 RNAP has high-level translation efficiency with low inflammatory stimulation. Cell Insight. 2022;1(5):100056.","journal-title":"Cell Insight"},{"key":"1277_CR135","doi-asserted-by":"publisher","first-page":"1017934","DOI":"10.3389\/fbioe.2022.1017934","volume":"10","author":"S Nagaraj","year":"2022","unstructured":"Nagaraj S, Stankiewicz-Drogon A, Darzynkiewicz E, Grzela R. RNA sensor response in HeLa cells for transfected mRNAs prepared in vitro by SP6 and HiT7 RNA polymerases: a comparative study. Front Bioeng Biotechnol. 2022;10:1017934.","journal-title":"Front Bioeng Biotechnol"},{"issue":"sup1","key":"1277_CR136","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/15476286.2021.1954808","volume":"18","author":"H Wu","year":"2021","unstructured":"Wu H, Wei T, Yu B, Cheng R, Huang F, Lu X, et al. A single mutation attenuates both the transcription termination and RNA-dependent RNA polymerase activity of T7 RNA polymerase. RNA Biol. 2021;18(sup1):451\u201366.","journal-title":"RNA Biol"},{"issue":"14","key":"1277_CR137","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.1093\/nar\/gkae593","volume":"52","author":"B Yu","year":"2024","unstructured":"Yu B, Chen Y, Yan Y, Lu X, Zhu B. DNA-terminus-dependent transcription by T7 RNA polymerase and its C-helix mutants. Nucleic Acids Res. 2024;52(14):8443\u201353.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1277_CR138","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41587-022-01525-6","volume":"41","author":"A Dousis","year":"2023","unstructured":"Dousis A, Ravichandran K, Hobert EM, Moore MJ, Rabideau AE. An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts. Nat Biotechnol. 2023;41(4):560\u20138.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"1277_CR139","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1111\/febs.70051","volume":"292","author":"Q Tang","year":"2025","unstructured":"Tang Q, Zhu S, Hu N, Yin S, Yang Y, Teng Y, et al. Engineered T7 RNA polymerase reduces dsRNA formation by lowering terminal transferase and RNA-dependent RNA polymerase activities. FEBS J. 2025;292(12):3205\u201323.","journal-title":"FEBS J"},{"issue":"0","key":"1277_CR140","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1039\/D4FD00023D","volume":"252","author":"M Miller","year":"2024","unstructured":"Miller M, Alvizo O, Baskerville S, Chintala A, Chng C, Dassie J, et al. An engineered T7 RNA polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis. Faraday Discuss. 2024;252(0):431\u201349.","journal-title":"Faraday Discuss"},{"issue":"1","key":"1277_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2024.2321764","volume":"21","author":"C Francis","year":"2024","unstructured":"Francis C, Frida JP, Thanh-Huong B, Alicja M, Artem K, J\u00e9r\u00e9mie P, et al. Urea supplementation improves mRNA in vitro transcription by decreasing both shorter and longer RNA byproducts. RNA Biol. 2024;21(1):1\u20136.","journal-title":"RNA Biol"},{"issue":"3","key":"1277_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100999","volume":"297","author":"E Cavac","year":"2021","unstructured":"Cavac E, Ram\u00edrez-Tapia LE, Martin CT. High-salt transcription of DNA cotethered with T7 RNA polymerase to beads generates increased yields of highly pure RNA. J Biol Chem. 2021;297(3):100999.","journal-title":"J Biol Chem"},{"issue":"1","key":"1277_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59978-5","volume":"14","author":"Y Sari","year":"2024","unstructured":"Sari Y, Sousa Rosa S, Jeffries J, Marques MPC. Comprehensive evaluation of T7 promoter for enhanced yield and quality in mRNA production. Sci Rep. 2024;14(1):9655.","journal-title":"Sci Rep"},{"issue":"6","key":"1277_CR144","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad027","volume":"51","author":"K MalagodaPathiranage","year":"2023","unstructured":"MalagodaPathiranage K, Cavac E, Chen T-H, Roy B, Martin Craig T. High-salt transcription from enzymatically gapped promoters nets higher yields and purity of transcribed RNAs. Nucleic Acids Res. 2023;51(6):e36.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"1277_CR145","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz700","volume":"47","author":"Y Gholamalipour","year":"2019","unstructured":"Gholamalipour Y, Johnson WC, Martin CT. Efficient inhibition of RNA self-primed extension by addition of competing 3\u2019-capture DNA-improved RNA synthesis by T7 RNA polymerase. Nucleic Acids Res. 2019;47(19):e118.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1277_CR146","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"1833","unstructured":"Karik\u00f3 K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther. 1833;16(11):1833\u201340.","journal-title":"Mol Ther"},{"key":"1277_CR147","unstructured":"European Medicines Agency. Guideline on the quality aspects of mRNA vaccines (draft). Amsterdam (Netherlands): European Medicines Agency; 2025. Report No. EMA\/CHMP\/BWP\/82416\/2025."},{"issue":"5","key":"1277_CR148","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4155\/tde-2016-0006","volume":"7","author":"AM Reichmuth","year":"2016","unstructured":"Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. MRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319\u201334.","journal-title":"Ther Deliv"},{"issue":"46","key":"1277_CR149","doi-asserted-by":"publisher","first-page":"23068","DOI":"10.1073\/pnas.1821754116","volume":"116","author":"DE Eyler","year":"2019","unstructured":"Eyler DE, Franco MK, Batool Z, Wu MZ, Dubuke ML, Dobosz-Bartoszek M, et al. Pseudouridinylation of mRNA coding sequences alters translation. Proc Natl Acad Sci USA. 2019;116(46):23068\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1277_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.901510","volume":"10","author":"A Liu","year":"2022","unstructured":"Liu A, Wang X. The pivotal role of chemical modifications in mRNA therapeutics. Front Cell Dev Biol. 2022;10:901510.","journal-title":"Front Cell Dev Biol"},{"key":"1277_CR151","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","volume":"217","author":"O Andries","year":"2015","unstructured":"Andries O, Mc Cafferty S, De Smedt SC, Weiss R, Sanders NN, Kitada T. N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J Control Release. 2015;217:337\u201344.","journal-title":"J Control Release"},{"issue":"10","key":"1277_CR152","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1093\/nar\/gkx135","volume":"45","author":"YV Svitkin","year":"2017","unstructured":"Svitkin YV, Cheng YM, Chakraborty T, Presnyak V, John M, Sonenberg N. N1-methyl-pseudouridine in mRNA enhances translation through eIF2\u03b1-dependent and independent mechanisms by increasing ribosome density. Nucleic Acids Res. 2017;45(10):6023\u201336.","journal-title":"Nucleic Acids Res"},{"key":"1277_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2021.06.020","volume":"131","author":"M Gao","year":"2021","unstructured":"Gao M, Zhang Q, Feng XH, Liu J. Synthetic modified messenger RNA for therapeutic applications. Acta Biomater. 2021;131:1\u201315.","journal-title":"Acta Biomater"},{"key":"1277_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.789427","volume":"9","author":"P Morais","year":"2021","unstructured":"Morais P, Adachi H, Yu YT. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front Cell Dev Biol. 2021;9:789427.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"1277_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12060624","volume":"12","author":"M Sioud","year":"2024","unstructured":"Sioud M, Juzeniene A, S\u00e6b\u00f8e-Larssen S. Exploring the impact of mRNA modifications on translation efficiency and immune tolerance to self-antigens. Vaccines (Basel). 2024;12(6):624.","journal-title":"Vaccines (Basel)"},{"issue":"26","key":"1277_CR156","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301606120","volume":"120","author":"E Ben-Akiva","year":"2023","unstructured":"Ben-Akiva E, Karlsson J, Hemmati S, Yu H, Tzeng SY, Pardoll DM, et al. Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination. Proc Natl Acad Sci USA. 2023;120(26):e2301606120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"1277_CR157","doi-asserted-by":"publisher","first-page":"30701","DOI":"10.1021\/acsnano.4c09902","volume":"18","author":"Z Luo","year":"2024","unstructured":"Luo Z, Lin Y, Meng Y, Li M, Ren H, Shi H, et al. Spleen-targeted mRNA vaccine doped with manganese adjuvant for robust anticancer immunity in vivo. ACS Nano. 2024;18(44):30701\u201315.","journal-title":"ACS Nano"},{"key":"1277_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1294929","volume":"14","author":"B Clemente","year":"2023","unstructured":"Clemente B, Denis M, Silveira CP, Schiavetti F, Brazzoli M, Stranges D. Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design. Front Immunol. 2023;14:1294929.","journal-title":"Front Immunol"},{"key":"1277_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122678","author":"M Hasan","year":"2023","unstructured":"Hasan M, Khatun A, Kogure K. Intradermal delivery of naked mRNA vaccines via iontophoresis. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15122678.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1277_CR160","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40824-023-00425-3","volume":"27","author":"M Yuan","year":"2023","unstructured":"Yuan M, Han Z, Liang Y, Sun Y, He B, Chen W, et al. mRNA nanodelivery systems: targeting strategies and administration routes. Biomater Res. 2023;27(1):90.","journal-title":"Biomater Res"},{"key":"1277_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2024.102499","volume":"81","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Wang ZM, Song D, Chen M, Xu Q. Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery. Curr Opin Chem Biol. 2024;81:102499.","journal-title":"Curr Opin Chem Biol"},{"issue":"17","key":"1277_CR162","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.7150\/thno.77259","volume":"12","author":"HN Jung","year":"2022","unstructured":"Jung HN, Lee SY, Lee S, Youn H, Im HJ. Lipid nanoparticles for delivery of RNA therapeutics: current status and the role of in vivo imaging. Theranostics. 2022;12(17):7509\u201331.","journal-title":"Theranostics"},{"issue":"4","key":"1277_CR163","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1021\/acs.biomac.4c01820","volume":"26","author":"JH Lam","year":"2025","unstructured":"Lam JH, Sinsinbar G, Loo SY, Chia TW, Lee YJ, Fong JY, et al. Development of thermostable and immunogenic block copolymer nanoparticles (BNPs) for mRNA delivery. Biomacromol. 2025;26(4):2444\u201357.","journal-title":"Biomacromol"},{"issue":"11","key":"1277_CR164","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s11095-022-03398-5","volume":"39","author":"R Skelton","year":"2022","unstructured":"Skelton R, Roach A, Prudhomme LE, Cen Feng JYC, Gaikwad P, Williams RM. Formulation of lipid-free polymeric mesoscale nanoparticles encapsulating mRNA. Pharm Res. 2022;39(11):2699\u2013707.","journal-title":"Pharm Res"},{"issue":"5","key":"1277_CR165","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1208\/s12248-023-00844-z","volume":"25","author":"H Kim","year":"2023","unstructured":"Kim H, Kirtane AR, Kim NY, Rajesh NU, Tang C, Ishida K, et al. Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles. Aaps j. 2023;25(5):81.","journal-title":"Aaps j"},{"key":"1277_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122781","author":"H Kim","year":"2023","unstructured":"Kim H, Ahn YR, Kim M, Choi J, Shin S, Kim HO. Charge-complementary polymersomes for enhanced mRNA delivery. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15122781.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1277_CR167","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12951-024-02634-x","volume":"22","author":"Z Iqbal","year":"2024","unstructured":"Iqbal Z, Rehman K, Mahmood A, Shabbir M, Liang Y, Duan L, et al. Exosome for mRNA delivery: strategies and therapeutic applications. J Nanobiotechnology. 2024;22(1):395.","journal-title":"J Nanobiotechnology"},{"issue":"42","key":"1277_CR168","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407619","volume":"11","author":"AM Zickler","year":"2024","unstructured":"Zickler AM, Liang X, Gupta D, Mamand DR, De Luca M, Corso G, et al. Novel Endogenous Engineering Platform for Robust Loading and Delivery of Functional mRNA by Extracellular Vesicles. Adv Sci (Weinh). 2024;11(42):e2407619.","journal-title":"Adv Sci (Weinh)"},{"issue":"17","key":"1277_CR169","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/eurheartj\/ehae883","volume":"46","author":"Y You","year":"2025","unstructured":"You Y, Tian Y, Guo R, Shi J, Kwak KJ, Tong Y, et al. Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity. Eur Heart J. 2025;46(17):1662\u201376.","journal-title":"Eur Heart J"},{"key":"1277_CR170","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.omtm.2022.03.013","volume":"25","author":"G Palladino","year":"2022","unstructured":"Palladino G, Chang C, Lee C, Music N, De Souza I, Nolasco J, et al. Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models. Mol Ther Methods Clin Dev. 2022;25:225\u201335.","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-026-01277-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:07:00Z","timestamp":1785514020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12929-026-01277-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1186\/s12929-026-01277-4","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used ChatGPT and Google Gemini to improve the language of the manuscript. After using these tools, the authors reviewed and edited the content as needed and took full responsibility for the content of the publication.","order":3,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"79"}}